Viewing Study NCT03946969


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-02-20 @ 10:10 PM
Study NCT ID: NCT03946969
Status: UNKNOWN
Last Update Posted: 2022-07-19
First Post: 2019-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module